Previous 10 |
home / stock / nvytf / nvytf news
Aimed a supporting the National Health Service's needs for COVID-19 testing, Novacyt (NVYTF) inks a new supply contract with the U.K. Department of Health and Social Care ((DHSC)) for its q16 and q32 Rapid-PCR instrument platforms, exsig COVID-19 Direct kits and genesig SARS-CoV-2 W...
Novacyt ( OTC:NVYTF ) launches its CE-Mark'd two-gene COVID-19 test molecular test in countries requiring a two-gene testing approach to detect the presence of SARS-CoV-2, including France, Belgium, Croatia, Poland and the UAE. More news on: Novacyt S.A., Healthcare stocks news, Re...
Novacyt ( OTC:NVYTF ) provides an update on its polymerase chain reaction (PCR) test for COVID-19. More news on: Novacyt Clamart, Healthcare stocks news, Read more ...
Novacyt S.A. ( OTC:NVYTF ) announces that it has sold, received orders or has contracted to deliver over £90 million (€103 million) of its COVID-19 polymerase chain reaction (PCR) test, including a supply agreement with the UK's Department of Health and Social Care and initial ...
France-based Novacyt S.A. ( OTC:NVYTF -29.9% ) announces that unit Primerdesign has achieved a production run-rate of 4M per month of its COVID-19 molecular test with plans to scale up to 8M per month. More news on: Novacyt Clamart, Healthcare stocks news, Read more ...